The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...
A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...
The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...
Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic ...
The FDA's move may change how doctors treat chronic kidney disease, which, according to Ozempic maker Novo Nordisk, affects around 37 million Americans and is one of the leading causes of death in the ...